Table 2 |
|||||
|
Test result of studies (Insufficient Samples Classified as Positive) |
|||||
|
study |
test result |
Patients number |
|||
|
|
|||||
|
TP |
FP |
FN |
TN |
||
|
|
|||||
|
Walker et al.[33] |
95 |
11 |
0 |
19 |
125 |
|
Kanchanabat et al.[11] |
8 |
13 |
0 |
26 |
47 |
|
Pisano et al.[12] |
80 |
149 |
17 |
183 |
429 |
|
Farshid et al.[35] |
92 |
173 |
2 |
880 |
1147 |
|
Gent et al.[37] |
39 |
38 |
1 |
109 |
187 |
|
Wanebo et al.[38] |
135 |
18 |
1 |
102 |
256 |
|
Apesteguia et al.[39] |
2 |
36 |
0 |
107 |
145 |
|
Ishikawa et al.[44] |
156 |
44 |
4 |
178 |
382 |
|
Leifland et al.[46] |
406 |
37 |
52 |
27 |
522 |
|
Sauer et al.[32] |
382 |
82 |
47 |
321 |
832 |
|
Wang et al.[50] |
119 |
5 |
7 |
55 |
186 |
|
|
|||||
|
TP:true positive; FP: false positive; FN:false negative; TN: true negative. |
|||||
|
Yu et al. BMC Cancer 2012 12:41 doi:10.1186/1471-2407-12-41 |
|||||